Literature DB >> 16297585

[Linezolid, the first oxazolidinone antibiotic].

H Dutronc1, F Bocquentin, T Galpérine, S Lafarie-Castet, M Dupon.   

Abstract

The spread of multiresistant Staphylococcus and Enterococcus strains required the development of new drugs. Linezolid is the first molecule of a new antibiotic family, oxazolidinones, with an original mechanism of action. In this general review, the authors first present its antibacterial activity, its pharmacokinetic properties, its therapeutic uses in serious Gram-positive infections, pneumonia, skin and soft tissue infections, and also in other indications. They then explain the rules for administration and tolerability.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16297585     DOI: 10.1016/j.medmal.2005.09.006

Source DB:  PubMed          Journal:  Med Mal Infect        ISSN: 0399-077X            Impact factor:   2.152


  2 in total

1.  Pharmacokinetics of linezolid in plasma and cerebrospinal fluid in patients with cerebral hemorrhage post-surgical intervention.

Authors:  Yan Tang; Lingti Kong; Chenchen Wu; Xiaohua Zhang; Guoyu Lu; Xiaofei Wu
Journal:  Eur J Clin Pharmacol       Date:  2017-03-24       Impact factor: 2.953

2.  Antimicrobial stewardship and linezolid.

Authors:  Pauline Guillard; Arnaud de La Blanchardière; Vincent Cattoir; Marc-Olivier Fischer; Renaud Verdon; Guillaume Saint-Lorant
Journal:  Int J Clin Pharm       Date:  2014-08-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.